Omada Health (OMDA) president sells 8,866 shares in Rule 10b5-1 trade

Rhea-AI Filing Summary

Omada Health, Inc. President Wei-Li Shao reported a sale of 8,866 shares of common stock on August 12, 2026 at $25.0167 per share in an open market or private transaction. The transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026, and left the reporting person with 307,372 shares held directly.

Insider Trade Summary 10b5-1

Net Seller: 8,866 shares

Net Sell 1 txn

Insider Shao Wei-Li

Role President

Sold 8,866 shs ($222K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	8,866	$25.0167	$222K

Holdings After Transaction: Common Stock — 307,372 shares (Direct)

Footnotes (1)

1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Key Figures

Shares sold: 8,866 shares Sale price: $25.0167 per share Shares owned after transaction: 307,372 shares +1 more

4 metrics

Shares sold 8,866 shares Common stock sale on August 12, 2026

Sale price $25.0167 per share Price for the 8,866 shares of common stock sold

Shares owned after transaction 307,372 shares Direct holdings reported following the sale

Net insider share change 8,866 shares Net-sell direction per transaction summary

Key Terms

Rule 10b5-1 trading plan, open market or private transaction, Form 4

3 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open market or private transaction financial

"transaction code description indicates a Sale in open market or private transaction"

Form 4 regulatory

"INSIDER FILING DATA (Form 4) describing insider transactions in issuer equity"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What insider transaction did Omada Health (OMDA) report on this Form 4?

Omada Health (OMDA) reported that President Wei-Li Shao sold 8,866 shares of common stock on August 12, 2026 in an open market or private transaction at $25.0167 per share.

How many Omada Health (OMDA) shares does Wei-Li Shao hold after this sale?

After the reported sale, President Wei-Li Shao holds 307,372 shares of Omada Health common stock directly, as disclosed in the Form 4 insider ownership table.

Was the Omada Health (OMDA) insider sale made under a Rule 10b5-1 plan?

Yes. The Form 4 states the transaction was made under a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026, indicating it was pre-arranged.

What price did Wei-Li Shao receive per Omada Health (OMDA) share in this transaction?

The reported sale price was $25.0167 per share for the 8,866 shares of Omada Health common stock sold on August 12, 2026, described as an open market or private transaction.

What is the net share direction of this Omada Health (OMDA) Form 4 filing?

The filing reflects a net sale of 8,866 shares, with the transaction summary showing a net-sell direction and no purchases or derivative exercises reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 04:50 PM Accepted by SEC EDGAR 08/12/2026 - 04:50 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shao Wei-Li

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2026		S(1)		8,866	D	$25.0167	307,372	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

	/s/ Nathan Salha, as Attorney-in-Fact for Wei-Li Shao	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)